-challenges for the csl/pfizer animal ethics committee john phelps csl biotherapies meeting animal...
TRANSCRIPT
- Challenges for the CSL/Pfizer Challenges for the CSL/Pfizer Animal Ethics CommitteeAnimal Ethics Committee
John PhelpsJohn Phelps
CSL BiotherapiesCSL Biotherapies
Meeting Animal Welfare Meeting Animal Welfare Needs in a Biotherapies Needs in a Biotherapies
EnvironmentEnvironment
Scope of Activities
Human (CSL) & Animal (Pfizer) Biotherapies
Vaccines Antiserum products Recombinant Biologicals
40:40 (New: Ext) Applications Year Quality Control Testing of Therapeutic
Products Production of Biological materials R&D of New Vaccines & Biotherapies
Animal Facilities Laboratory animals
Mice/Guinea Pigs/Rabbits/Ferrets Housed animals
Dogs/Cats/Poultry/Pigs Livestock
Cattle/Sheep/Horses
AEC Membership
Serving the AEC needs of 2 institutions confidentiality requirements of internal members differences in lines of company reporting maintaining balanced AEC membership
Recruitment availability of C & D Categories identifying potential members selection of the right members
Maintenance site inductions and car parking workloads at critical times work hour incompatibility communications & conferencing limited need for conflict resolution
Science vs Animal Welfare discussions if the science isn’t right, animals will be wasted scientific vs lay language in applications
Meeting all Regulatory Codes
Pharmacopeia requirements vs test refinement test procedures must follow compendial methods recognition of invention points is critical test alternatives are being introduced
Quarantine restrictions - animal care and fate physical containment vs environmental enrichment approved disposal method vs animal fate
Environmental codes vs cage enrichment waste management codes - animal exercise areas effluent codes and cage washing methods air change rates may affect global warming!
Interstate projects - regulatory differences differences in site licence conditions
Codes are often complementary e.g. requirements for animal welfare reinforced in
major biotherapy manufacturing Codes (GMP, GCP)
Recognition of Training
New research methods/techniques how are the merits of new techniques
gauged? who will identify the right system? feedback is critical
Proof of expertise – what is acceptable? recognition of trainers does experience necessarily confer
expertise?
Maintenance of a training database where is the data stored when and how is it updated methods for AEC approval of changes
Other Items
Ensuring Closure of all AEC Action items methods of monitoring and reporting
AEC Communication channels project investigator availability animal facilities/updates/feedback executive management of 2
companies roles of Chairperson and Secretary
Training of new investigators using the right (lay) language why and what the AEC needs to know applications in on time!
The End